Solventum Nears Inflection Point As It Begins to Unlock Value
Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers.
1 source
·13h ago
